Endocrinology, Vol 127, 191-199, Copyright © 1990 by Endocrine Society

ARTICLES

Calcitonin decreases thyrotropin-releasing hormone-stimulated prolactin release through a mechanism that involves inhibition of inositol phosphate production

AM Judd, T Kubota, SI Kuan, WD Jarvis, BL Spangelo and RM Macleod
Department of Internal Medicine, University of Virginia Health Sciences Center, Charlottesville 22908.

Calcitonin is present in both the hypothalamus and pituitary of the rat, and normal rat anterior pituitary cells express calcitonin receptors. Calcitonin has been reported to inhibit or to stimulate PRL release from rat anterior pituitary cells. We have investigated the effects of salmon calcitonin on basal and stimulated PRL release from rat anterior pituitary cells and have studied the effects of this peptide on the intracellular biochemical pathways involved in PRL release. Salmon calcitonin had no significant effect on basal PRL release, but inhibited (P less than 0.01) TRH-stimulated PRL release without affecting PRL release promoted by angiotensin II, neurotensin, phorbol myristate acetate (a protein kinase C activator), or maitotoxin (a calcium channel activator). Salmon calcitonin had no effect on the increase in PRL release and intracellular cAMP concentration after exposure of pituitary cells to vasoactive intestinal peptide or forskolin. Salmon calcitonin significantly decreased (P less than 0.01) the TRH-stimulated rise in inositol phosphates without affecting the angiotensin II-stimulated increase in inositol phosphates. Similarly, salmon calcitonin decreased the TRH-stimulated increase in cytosolic calcium and arachidonate liberation by pituitary cells. We conclude that salmon calcitonin selectively decreases TRH-stimulated PRL release by a mechanism that involves a decrease in inositol phosphate production, as well as a subsequent reduction in cytosolic calcium levels and in arachidonate liberation.

This article has been cited by other articles:

				S. Chigurupati, T. Kulkarni, S. Thomas, and G. Shah Calcitonin Stimulates Multiple Stages of Angiogenesis by Directly Acting on Endothelial Cells Cancer Res., September 15, 2005; 65(18): 8519 - 8529. [Abstract] [Full Text] [PDF]

				Y. Q. Wang, R. Yuan, Y.-P. Sun, T.-J. Lee, and G. V. Shah Antiproliferative Action of Calcitonin on Lactotrophs of the Rat Anterior Pituitary Gland: Evidence for the Involvement of Transforming Growth Factor {beta}1 in Calcitonin Action Endocrinology, May 1, 2003; 144(5): 2164 - 2171. [Abstract] [Full Text] [PDF]

				Y.-P. Sun, T. J. Lee, and G. V. Shah Calcitonin Expression in Rat Anterior Pituitary Gland Is Regulated by Ovarian Steroid Hormones Endocrinology, October 1, 2002; 143(10): 4056 - 4064. [Abstract] [Full Text] [PDF]

				M. E. Freeman, B. Kanyicska, A. Lerant, and G. Nagy Prolactin: Structure, Function, and Regulation of Secretion Physiol Rev, October 1, 2000; 80(4): 1523 - 1631. [Abstract] [Full Text] [PDF]

				G. V. Shah, J. Chien, Y. P. Sun, S. Puri, and R. Ravindra Calcitonin Inhibits Anterior Pituitary Cell Proliferation in the Adult Female Rats Endocrinology, September 1, 1999; 140(9): 4281 - 4291. [Abstract] [Full Text]

				L. A. Arbogast, G. V. Shah, and J. L. Voogt 3',5' Cyclic Adenosine Monophosphate Mediates the Salmon Calcitonin-Induced Increase in Hypothalamic Tyrosine Hydroxylase Activity Endocrinology, July 1, 1999; 140(7): 3273 - 3281. [Abstract] [Full Text]